Comparing 0 vendors in Viral Vector and Plasmid DNA Manufacturing across 0 criteria.
The Viral Vector & Plasmid DNA Manufacturing Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Viral Vector & Plasmid DNA Manufacturing. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 40 companies of which the Top 24 Viral Vector & Plasmid DNA Manufacturing Companies were categorized and recognized as the quadrant leaders.
Contenders
Emerging Companies
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
2.1 DRIVERS
2.1.1 Rising prevalence of genetic disorders, cancer, and infectious diseases
2.1.2 Availability of funding for development of gene therapy
2.1.3 Effectiveness of viral vectors
2.1.4 Ongoing research on viral vector-based gene and cell therapies
2.2 RESTRAINTS
2.2.1 High operational costs associated with cell and gene therapy manufacturing
2.2.2 Short shelf life of viral vectors
2.3 OPPORTUNITIES
2.3.1 Smart capital deployment and planning for scalability
2.3.2 Leveraging digital tools to facilitate operational excellence
2.4 CHALLENGES
2.4.1 Risk of mutagenesis and other unwanted outcomes
2.4.2 Individual optimization and low yield
3.1 INTRODUCTION
3.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
3.3 MARKET SHARE ANALYSIS
3.4 REVENUE SHARE ANALYSIS
3.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
3.5.1 STARS
3.5.2 EMERGING LEADERS
3.5.3 PERVASIVE PLAYERS
3.5.4 PARTICIPANTS
3.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
3.6.1 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
3.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
3.7 COMPETITIVE SCENARIO AND TRENDS
3.7.1 PRODUCT & SERVICE LAUNCHES
3.7.2 DEALS
3.7.3 OTHERE DEVELOPMENTS
4.1 KEY PLAYERS
4.1.1 LONZA GROUP
4.1.1.1 Business overview
4.1.1.2 Products & services offered
4.1.1.3 Recent developments
4.1.1.4 MnM view
4.1.2 MERCK KGAA
4.1.2.1 Business overview
4.1.2.2 Products & services offered
4.1.2.3 Recent developments
4.1.2.4 MnM view
4.1.3 THERMO FISHER SCIENTIFIC INC.
4.1.3.1 Business overview
4.1.3.2 Products & services offered
4.1.3.3 Recent developments
4.1.3.4 MnM view
4.1.4 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
4.1.4.1 Business overview
4.1.4.2 Products & services offered
4.1.4.3 Recent developments
4.1.5 CATALENT, INC.
4.1.5.1 Business overview
4.1.5.2 Products & services offered
4.1.5.3 Recent developments
4.1.6 WUXI APPTEC CO., LTD.
4.1.6.1 Business overview
4.1.6.2 Products & services offered
4.1.6.3 Recent developments
4.1.7 FUJIFILM CORPORATION
4.1.7.1 Business overview
4.1.7.2 Products & services offered
4.1.7.3 Recent developments
4.1.8 GENSCRIPT BIOTECH CORPORATION
4.1.8.1 Business overview
4.1.8.2 Products & services offered
4.1.8.3 Recent developments
4.1.9 TAKARA BIO INC.
4.1.9.1 Business overview
4.1.9.2 Products & services offered
4.1.9.3 Recent developments
4.1.10 OXFORD BIOMEDICA
4.1.10.1 Business overview
4.1.10.2 Products & services offered
4.1.10.3 Recent developments
4.1.11 NOVARTIS AG
4.1.11.1 Business overview
4.1.11.2 Products & services offered
4.1.11.3 Recent developments
4.1.12 PRECISION BIOSCIENCES
4.1.12.1 Business overview
4.1.12.2 Products & services offered
4.1.12.3 Recent developments
4.1.13 BLUEBIRD BIO, INC.
4.1.13.1 Business overview
4.1.13.2 Products & services offered
4.1.14 SARTORIUS AG
4.1.14.1 Business overview
4.1.14.2 Products & services offered
4.1.14.3 Recent developments
4.1.15 DANAHER CORPORATION
4.1.15.1 Business overview
4.1.15.2 Products & services offered
4.1.15.3 Recent developments
4.1.16 SIRION BIOTECH
4.1.16.1 Business overview
4.1.16.2 Products & services offered
4.1.16.3 Recent developments
4.2 OTHER PLAYERS
4.2.1 VGXI, INC.
4.2.2 KANEKA EUROGENTEC S.A.
4.2.3 PLASMIDFACTORY GMBH
4.2.4 ADDGENE
4.2.5 CELL AND GENE THERAPY CATAPULT
4.2.6 BATAVIA BIOSCIENCES B.V.
4.2.7 ALTOGEN BIOSYSTEMS
Company Profiles
Strategy, financials, growth, and SWOT
Market Insights
Visual quadrant of competitors and leaders
Benchmarking
Compare by product, region, and end-user
Lead Gen Add-on
Use the quadrant to attract clients
Plasmid DNA is a critical raw material used in the production of viral vectors. It provides the genetic template required for the viral vector's functionality.
The process must comply with standards set by regulatory agencies like the FDA, EMA, and ICH, focusing on Good Manufacturing Practices (GMP) to ensure product safety, efficacy, and quality.
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Email : [email protected]
Quick Links
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Company
Headquarters
Year Founded
Holding Type